[GP IIb/III antagonists for the optimization of fibrinolysis. Simple management through rapid start of action and easy manageability].
D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D003643:Death; D000077542:Eptifibatide; D005342:Fibrinolysis; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide